IBDEI063 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7896,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,7896,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,7897,0)
 ;;=425.18^^60^576^61
 ;;^UTILITY(U,$J,358.3,7897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7897,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,7897,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,7897,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,7898,0)
 ;;=V12.55^^60^576^50
 ;;^UTILITY(U,$J,358.3,7898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7898,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,7898,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,7898,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,7899,0)
 ;;=414.4^^60^576^16
 ;;^UTILITY(U,$J,358.3,7899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7899,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,7899,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,7899,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,7900,0)
 ;;=271.3^^60^577^17
 ;;^UTILITY(U,$J,358.3,7900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7900,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,7900,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,7900,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,7901,0)
 ;;=611.1^^60^577^22
 ;;^UTILITY(U,$J,358.3,7901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7901,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,7901,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,7901,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,7902,0)
 ;;=704.1^^60^577^23
 ;;^UTILITY(U,$J,358.3,7902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7902,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,7902,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,7902,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,7903,0)
 ;;=251.2^^60^577^36
 ;;^UTILITY(U,$J,358.3,7903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7903,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,7903,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,7903,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,7904,0)
 ;;=257.2^^60^577^37
 ;;^UTILITY(U,$J,358.3,7904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7904,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,7904,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,7904,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,7905,0)
 ;;=253.2^^60^577^41
 ;;^UTILITY(U,$J,358.3,7905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7905,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,7905,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,7905,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,7906,0)
 ;;=733.00^^60^577^52
 ;;^UTILITY(U,$J,358.3,7906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7906,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,7906,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,7906,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,7907,0)
 ;;=278.00^^60^577^48
 ;;^UTILITY(U,$J,358.3,7907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7907,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,7907,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,7907,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,7908,0)
 ;;=278.01^^60^577^47
 ;;^UTILITY(U,$J,358.3,7908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7908,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,7908,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,7908,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,7909,0)
 ;;=250.80^^60^577^15
 ;;^UTILITY(U,$J,358.3,7909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7909,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,7909,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,7909,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,7910,0)
 ;;=250.00^^60^577^9
 ;;^UTILITY(U,$J,358.3,7910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7910,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,7910,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,7910,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,7911,0)
 ;;=250.40^^60^577^11
 ;;^UTILITY(U,$J,358.3,7911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7911,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,7911,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,7911,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,7912,0)
 ;;=250.50^^60^577^14
 ;;^UTILITY(U,$J,358.3,7912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7912,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7912,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,7912,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,7913,0)
 ;;=250.60^^60^577^12
 ;;^UTILITY(U,$J,358.3,7913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7913,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,7913,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,7913,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,7914,0)
 ;;=250.70^^60^577^13
 ;;^UTILITY(U,$J,358.3,7914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7914,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,7914,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,7914,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,7915,0)
 ;;=250.01^^60^577^8
 ;;^UTILITY(U,$J,358.3,7915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7915,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,7915,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,7915,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,7916,0)
 ;;=272.0^^60^577^28
 ;;^UTILITY(U,$J,358.3,7916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7916,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,7916,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,7916,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,7917,0)
 ;;=272.1^^60^577^33
 ;;^UTILITY(U,$J,358.3,7917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7917,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,7917,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,7917,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,7918,0)
 ;;=272.2^^60^577^30
 ;;^UTILITY(U,$J,358.3,7918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7918,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,7918,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,7918,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,7919,0)
 ;;=275.42^^60^577^27
 ;;^UTILITY(U,$J,358.3,7919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7919,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,7919,1,5,0)
 ;;=5^Hypercalcaemia
 ;;^UTILITY(U,$J,358.3,7919,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,7920,0)
 ;;=275.41^^60^577^35
 ;;^UTILITY(U,$J,358.3,7920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7920,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,7920,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,7920,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,7921,0)
 ;;=276.7^^60^577^29
 ;;^UTILITY(U,$J,358.3,7921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7921,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,7921,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,7921,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,7922,0)
 ;;=275.2^^60^577^25
 ;;^UTILITY(U,$J,358.3,7922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7922,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,7922,1,5,0)
 ;;=5^Hyper or Hypomagnesaemia
 ;;^UTILITY(U,$J,358.3,7922,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,7923,0)
 ;;=276.0^^60^577^31
 ;;^UTILITY(U,$J,358.3,7923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7923,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,7923,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,7923,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,7924,0)
 ;;=276.1^^60^577^38
 ;;^UTILITY(U,$J,358.3,7924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7924,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,7924,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,7924,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,7925,0)
 ;;=275.3^^60^577^26
 ;;^UTILITY(U,$J,358.3,7925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7925,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,7925,1,5,0)
 ;;=5^Hyper or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,7925,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,7926,0)
 ;;=240.0^^60^577^20
 ;;^UTILITY(U,$J,358.3,7926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7926,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,7926,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,7926,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,7927,0)
 ;;=241.1^^60^577^19
 ;;^UTILITY(U,$J,358.3,7927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7927,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,7927,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,7927,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,7928,0)
 ;;=241.0^^60^577^59
 ;;^UTILITY(U,$J,358.3,7928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7928,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,7928,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,7928,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,7929,0)
 ;;=242.00^^60^577^21
 ;;^UTILITY(U,$J,358.3,7929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7929,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,7929,1,5,0)
 ;;=5^Graves' Disease
 ;;^UTILITY(U,$J,358.3,7929,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,7930,0)
 ;;=242.01^^60^577^18
 ;;^UTILITY(U,$J,358.3,7930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7930,1,4,0)
 ;;=4^242.01
 ;;^UTILITY(U,$J,358.3,7930,1,5,0)
 ;;=5^Goiter Diff Tox W Strm
 ;;^UTILITY(U,$J,358.3,7930,2)
 ;;=^267794
 ;;^UTILITY(U,$J,358.3,7931,0)
 ;;=252.1^^60^577^40
 ;;^UTILITY(U,$J,358.3,7931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7931,1,4,0)
 ;;=4^252.1
 ;;^UTILITY(U,$J,358.3,7931,1,5,0)
 ;;=5^Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,7931,2)
 ;;=^60635
 ;;^UTILITY(U,$J,358.3,7932,0)
 ;;=242.90^^60^577^32
 ;;^UTILITY(U,$J,358.3,7932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7932,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,7932,1,5,0)
 ;;=5^Hyperthyroid W/O Goiter Or Strm
 ;;^UTILITY(U,$J,358.3,7932,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,7933,0)
 ;;=242.91^^60^577^45
 ;;^UTILITY(U,$J,358.3,7933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7933,1,4,0)
 ;;=4^242.91
 ;;^UTILITY(U,$J,358.3,7933,1,5,0)
 ;;=5^Hyprthy W/O Goit W Strm
 ;;^UTILITY(U,$J,358.3,7933,2)
 ;;=^267812
 ;;^UTILITY(U,$J,358.3,7934,0)
 ;;=244.0^^60^577^43
 ;;^UTILITY(U,$J,358.3,7934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7934,1,4,0)
 ;;=4^244.0
